Chennai Meenakshi Multispeciality
45.00
+2.00(+4.65%)
Market Cap₹33.59 Cr
PE Ratio-35.25
Company Performance:
1D+4.65%
1M-9.00%
6M+33.14%
1Y+11.11%
5Y+234.57%
View Company Insightsright
More news about Chennai Meenakshi Multispeciality
05Sept 25
Chennai Meenakshi Multispeciality Hospital Announces Major Board Restructuring
Chennai Meenakshi Multispeciality Hospital Ltd. (CMMH) has approved significant changes to its board of directors. Key appointments include Mrs. Shama Dhilip and Mr. K. M. Mohandass as Independent Directors, and Mrs. Jayanthi Radhakrishnan as Managing Director. The restructuring involves several family members, including the daughter, son, and grandson of the current Managing Director, Mrs. R. Gomathi. Two groups of shareholders, each holding over 10% equity, have proposed additional directorships. These changes are subject to shareholder approval at the upcoming Annual General Meeting on September 30, 2025.
04Sept 25
Chennai Meenakshi Multispeciality Hospital Receives Director Nominations from Major Shareholder Groups
Two significant shareholder groups of Chennai Meenakshi Multispeciality Hospital Limited have proposed candidates for directorship at the upcoming 35th Annual General Meeting. The G. Ra. Gokul and Abhinaya Gokul Group, holding 10.06% of shares, nominated Gomathi Radhakrishnan Gokul. The Gautham Srinivas and Aravind Srinivas Group, with 10.88% shareholding, proposed K.P. Gautham Srinivas. Both groups complied with regulatory requirements, submitting the necessary Rs. 1.00 lakh deposit. The board has approved both proposals, and the resolutions will be included in the AGM notice.
28Aug 25
Chennai Meenakshi Multispeciality Hospital Receives Special Notice for Managing Director Appointment
Chennai Meenakshi Multispeciality Hospital Limited has received a special notice from three major shareholders, collectively holding 26.09% stake, proposing the appointment of Mrs. Jayanthi Radhakrishnan as the new Managing Director. The proposal will be discussed at the board meeting on September 3, 2025, and if approved, will be included in the upcoming Annual General Meeting notice, scheduled before September 30, 2025. The company has informed BSE Limited about this development under SEBI Listing Regulations.
16Aug 25
Chennai Meenakshi Hospital Reports Profit in Q1 Despite Revenue Decline
Chennai Meenakshi Multispeciality Hospital Limited announced Q1 financial results, showing a turnaround to profitability despite decreased revenue. The hospital reported a net profit of Rs. 0.64 crores, compared to a loss of Rs. 2.50 crores in the same quarter last year. Total income from operations declined to Rs. 17.30 crores from Rs. 24.00 crores year-over-year. Earnings Per Share (EPS) improved to Rs. 0.55 from negative Rs. 0.67. The results were approved by the Board of Directors and prepared in accordance with Indian Accounting Standards.
13Aug 25
Chennai Meenakshi Multispeciality Hospital Reports Widened Losses and Appoints New Directors
Chennai Meenakshi Multispeciality Hospital Limited (CMMH) reported a net loss of Rs 74.11 lakhs for Q1 FY24, a 93.55% increase from Rs 38.29 lakhs loss in Q1 FY23. Revenue from operations decreased by 1.12% to Rs 864.90 lakhs, while total expenses rose by 4.75% to Rs 967.47 lakhs. The company appointed two new Additional Directors, Mr. Edward M Prabhakar and Mr. Akash Prabhakar, effective August 13. Basic EPS declined to -Rs 0.99 from -Rs 0.51 year-over-year.
1 Year Returns:+11.11%
Industry Peers
Dr. Lal Path Labs
1,410.20
(-0.76%)
Metropolis Healthcare
1,884.50
(-1.17%)
Krsnaa Diagnostics
708.70
(-2.23%)
3B BlackBio DX
1,615.00
(+10.96%)
Suraksha Diagnostic
265.90
(-0.51%)
Sastasundar Ventures
322.15
(-2.36%)